Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
23.34
-0.25 (-1.06%)
Dec 24, 2024, 1:00 PM EST - Market closed
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $1.37 billion as of December 26, 2024. Its market cap has increased by 1,774.42% in one year.
Market Cap
1.37B
Enterprise Value
955.98M
1-Year Change
1,774.42%
Ranking
Category
Stock Price
$23.34
Market Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $1.37B, an increase of 1,126.68%. That is a compound annual growth rate of 33.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2024 | 1.20B | 1,278.19% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Schrödinger | 1.44B |
| InMode | 1.43B |
| Nurix Therapeutics | 1.42B |
| Immunocore Holdings | 1.41B |
| RxSight | 1.39B |
| Novavax | 1.38B |
| MiMedx Group | 1.36B |
| U.S. Physical Therapy | 1.36B |